Xinxin Wang Selected Research

ferrocenium (ferrocenium hexafluorophosphate)

1/2022

Cancer-Mitochondria Dual-Targeting Glycol/Ferrocenium-Based Polydopamine Nanoparticles for Synergistic Photothermal and Photodynamic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinxin Wang Research Topics

Disease

49	Neoplasms (Cancer) 03/2022 - 01/2010
10	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2017
9	Carcinogenesis 01/2020 - 01/2016
8	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2017
6	Inflammation (Inflammations) 01/2022 - 05/2014
5	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2019
5	COVID-19 06/2022 - 06/2020
5	Virus Diseases (Viral Diseases) 03/2022 - 01/2020
4	Stroke (Strokes) 08/2022 - 01/2020
4	Fibrosis (Cirrhosis) 12/2021 - 09/2017
4	Adenocarcinoma 01/2021 - 02/2019
4	Infections 12/2018 - 01/2014
3	Carcinoma (Carcinomatosis) 11/2021 - 01/2017
3	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2015
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2012
3	Hypoxia (Hypoxemia) 08/2020 - 04/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2018
2	Atopic Dermatitis (Atopic Eczema) 06/2022 - 08/2020
2	Lymphatic Metastasis 03/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 01/2020
2	Rectal Neoplasms (Rectal Cancer) 03/2022 - 01/2021
2	Hemorrhage 01/2022 - 01/2021
2	Embolism (Embolus) 01/2022 - 11/2020
2	Anemia 01/2022 - 10/2018
2	Dyslipidemias (Dyslipidemia) 12/2021 - 07/2013
2	Myocardial Infarction 12/2021 - 01/2019
2	Hypertension (High Blood Pressure) 12/2021 - 07/2013
2	Hypertrophy 12/2021 - 03/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 11/2019
2	Pain (Aches) 01/2021 - 01/2020
2	Paraganglioma (Paragangliomas) 01/2021 - 01/2010
2	Cytokine Release Syndrome 01/2021 - 08/2020
2	Thrombosis (Thrombus) 01/2021 - 11/2019
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2020
2	Pheochromocytoma 01/2021 - 01/2010
2	Brain Injuries (Brain Injury) 01/2021 - 11/2019
2	Cerebral Infarction 11/2020 - 01/2016
2	Necrosis 10/2020 - 11/2019
2	Type 2 Diabetes Mellitus (MODY) 10/2020 - 12/2019
2	Coronary Disease (Coronary Heart Disease) 10/2020 - 01/2020
2	Glioma (Gliomas) 12/2019 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2019 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2018 - 02/2018
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2016 - 05/2014
1	Allergic Rhinitis 11/2022
1	Gram-Negative Bacterial Infections 10/2022
1	Cognitive Dysfunction 08/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
14	Biomarkers (Surrogate Marker)IBA 08/2022 - 05/2013
8	Pharmaceutical PreparationsIBA 10/2022 - 12/2015
6	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2014
6	Therapeutic UsesIBA 01/2021 - 12/2015
5	AntigensIBA 03/2022 - 10/2017
4	Long Noncoding RNAIBA 03/2022 - 05/2013
4	Chimeric Antigen ReceptorsIBA 01/2022 - 10/2017
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Biological ProductsIBA 03/2022 - 01/2014
3	ResveratrolIBA 01/2022 - 02/2018
3	Circular RNAIBA 11/2021 - 12/2019
3	CytokinesIBA 10/2020 - 03/2016
3	Small Interfering RNA (siRNA)IBA 12/2018 - 01/2018
2	Contrast MediaIBA 11/2022 - 02/2022
2	Interleukin-17 (Interleukin 17)IBA 08/2022 - 12/2017
2	InterleukinsIBA 08/2022 - 10/2020
2	RNA IIBA 04/2022 - 01/2020
2	XELOXIBA 03/2022 - 10/2021
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 05/2014
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2021
2	metabotropic glutamate receptor 2IBA 12/2021 - 01/2018
2	gadolinium ethoxybenzyl DTPA FDA Link 10/2021 - 12/2020
2	Tripartite Motif ProteinsIBA 09/2021 - 11/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 04/2017
2	Peptides (Polypeptides)IBA 10/2020 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 07/2020 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2019
2	EnzymesIBA 01/2020 - 04/2015
2	Carcinoembryonic AntigenIBA 01/2020 - 09/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2016
2	ChromatinIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2019
2	LipidsIBA 10/2019 - 07/2013
2	Oncogene Proteins (Oncogene Protein)IBA 07/2019 - 05/2016
2	Competitive Endogenous RNAIBA 01/2019 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 12/2018 - 01/2016
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 08/2022
1	FlavonoidsIBA 06/2022

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2014
8	Drug Therapy (Chemotherapy) 04/2022 - 01/2017
4	Gastrectomy 10/2021 - 04/2017
4	Immunotherapy 01/2021 - 01/2017
3	Neoadjuvant Therapy 01/2021 - 02/2019
2	Radiotherapy 05/2022 - 01/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 04/2017